Researchers develop diagnostic model to detect COVID-related eye problems
July 8, 2026
Mild COVID-19 can cause severe and long-lasting eye problems, according to a study from Linköping University, Sweden.
Mild COVID-19 can cause severe and long-lasting eye problems, according to a study from Linköping University, Sweden.
Biohub researchers have performed what they believe is the first genome-wide CRISPR study of primary human adult skin cells, then used an AI model to mine the results for overlooked drug targets for psoriasis.
Stem cell transplantation (also called bone marrow transplantation) and gene therapy are among the most powerful curative approaches for blood diseases such as sickle cell disease, b-thalassemia, immune deficiencies and some blood cancers.
Vera Therapeutics’ atacicept, to be marketed as Trutakna, will go up against Novartis, Otsuka and possibly Vertex in the kidney disease primary IgA nephropathy after receiving an accelerated FDA approval.
Beckman Coulter’s assay is used to measure phosphorylated tau (pTau217) levels in the blood of individuals displaying signs of cognitive decline.
A new “tumor-on-a-chip” model is giving scientists a live look at how pancreatic cancer can recruit the body’s own immune cells to help tumors survive.
What happens to the human body in space may help scientists create new anti-aging therapies.
Parkinson’s disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people worldwide.
Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute and Heidelberg University Hospital (UKHD) have developed “HemaGuide,” an AI assistant that supports physicians in making difficult treatment decisions.
The Technical University of Munich (TUM) has developed a soft, pneumatic glove that restores the ability of people with paralyzed hands to grasp object